Neurocrine Biosciences, Inc. (NBIX) Posts Q3 EPS of $0.56, Revenues Rose 189% Y/Y
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $146.23 -3.69%
EPS Growth %: -12.4%
Financial Fact:
Total revenues: 0
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: -12.4%
Financial Fact:
Total revenues: 0
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) reported Q3 EPS of $0.56, which may not compare to the analyst estimate of $0.19. Revenue for the quarter came in at $41.6 million versus the consensus estimate of $21.64 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CCB Int'l Starts Neurocrine Bio. (NBIX) at Outperform
- Kroger (KR) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY27 EPS Guidance
- Saudi Arabia shuts East-West Pipeline after attacks
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
